Long-Term follow-up in Patients with Malignant Biliary Obstruction after Percutaneous Placement of Uncovered Wallstent Endoprostheses

Purpose: Evaluation of the treatment of malignant obstructive jaundice by percutaneous insertion of uncovered stents. Material and Methods: 51 patients (35 men, 16 women) with inoperable malignant biliary obstruction underwent percutaneous placement of uncovered Wallstent biliary endoprostheses. A t...

Full description

Saved in:
Bibliographic Details
Published in:Acta radiologica (1987) 1999-09, Vol.40 (5), p.528-533
Main Authors: Kaskarelis, Ioannis S., Papadaki, M. G., Papageorgiou, G. N., Limniati, M. D., Malliaraki, N. E., Piperopoulos, P. N.
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Cholangiography
Cholestasis - diagnostic imaging
Cholestasis - etiology
Cholestasis - mortality
Cholestasis - surgery
Female
Follow-Up Studies
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Length of Stay
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Neoplasms - complications
Neoplasms - diagnosis
Neoplasms - mortality
Palliative Care - methods
Prosthesis Implantation - methods
Retrospective Studies
Stents
Survival Rate
Treatment Outcome
Tumors
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: Evaluation of the treatment of malignant obstructive jaundice by percutaneous insertion of uncovered stents. Material and Methods: 51 patients (35 men, 16 women) with inoperable malignant biliary obstruction underwent percutaneous placement of uncovered Wallstent biliary endoprostheses. A total of 65 endoprostheses were inserted. Results: the technical success rate was 98%, and the procedure-related complications rate was 10%. Early complications rate within the first 30 days was 2%. the clinical success rate within the first 30 days was 98% and the 30-day mortality rate was 2%. the late complications rate was 16%. the overall stent occlusion rate was 18% at a mean of 288.4 days. Mean survival time of the 50 patients was 214 days, and the mean total duration of hospital stay was 9.8 days. Conclusions: the advantages of uncovered Wallstent endoprostheses justify their placement in patients with inoperable malignant obstructive jaundice since patients' quality of life is markedly improved. Stent insertion is associated with a low complication rate, most stents remain patent longer than the patients' survival time and patients' hospital stay is relatively short.
ISSN:0284-1851
1600-0455
DOI:10.3109/02841859909175579